The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
High Altitude Pulmonary Hypertension
Interventions
DRUG

Theophylline and Bambuterol

Treatment 3: Theophylline, 300 mg plus Bambuterol, 20 mg

Trial Locations (1)

0313

Institute of Aviation Medicine, Norwegian Armed Forces Medica, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Oslo University Hospital

OTHER

lead

Norwegian Armed Forces Medical Service

OTHER_GOV

NCT01566565 - The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension | Biotech Hunter | Biotech Hunter